Helicobacter pylori: screening recommended to prevent stomach cancer

· 5 min read · Dr Youssef BENNANI

Illustration of the stomach, the organ colonized by Helicobacter pylori

The International Agency for Research on Cancer (IARC), the WHO's specialized cancer agency, has issued guidance on screening for and treating Helicobacter pylori to prevent stomach cancer. It was summarized in March 2026 in the New England Journal of Medicine. Here are the key points.

What is Helicobacter pylori?

Helicobacter pylori is a bacterium that lives in the stomach. It is usually caught in childhood and can persist for life without causing symptoms. Yet it causes gastritis and stomach and duodenal ulcers, and it is the leading cause of stomach cancer. IARC classifies it as a definite human carcinogen.

What IARC recommends

In 2025, a working group of 35 experts from 20 countries convened by IARC published guidance on population-based H. pylori "screen-and-treat" programs. Its conclusions were summarized in March 2026 in the New England Journal of Medicine. Key points:

  • in regions where stomach cancer is moderately or highly common, a population-based H. pylori screen-and-treat program should be considered a public health priority;
  • in regions where it is less common, screening can target people at higher risk;
  • programs must ensure responsible antibiotic use to limit resistance.

According to an IARC-led study published in Nature Medicine, about three quarters of future stomach cancers worldwide would be attributable to H. pylori. Eliminating the bacterium could therefore prevent a large share of them.

How is screening done?

Several simple tests are available:

  • the urea breath test, done by breathing into a tube;
  • the stool antigen test;
  • serology (blood test);
  • biopsies taken during a gastroscopy, when the procedure is needed for other reasons.

Some medications, such as acid-reducing drugs (PPIs) and antibiotics, can affect breath and stool tests: always tell your doctor about them.

How is the infection treated?

Treatment combines an acid-reducing drug with several antibiotics, taken for 10 to 14 days. It is chosen with antibiotic resistance in mind. A follow-up test about a month after treatment is essential to confirm the bacterium is gone.

Who should see a doctor?

  • people with a close relative who had stomach cancer;
  • anyone with a current or past ulcer;
  • persistent stomach pain or heartburn;
  • unexplained iron-deficiency anemia;
  • before long-term aspirin or anti-inflammatory treatment, on medical advice.

Difficulty swallowing, repeated vomiting, weight loss or black stools require a prompt visit and often a gastroscopy. To learn more about this test, read Gastroscopy: 10 frequently asked questions.

Frequently asked questions

Is Helicobacter pylori contagious?

Yes, it is mostly transmitted in childhood within families, through saliva or contaminated water and food. Good hand and water hygiene reduces the risk.

No. The vast majority of infected people will never develop cancer. But the bacterium raises the risk, and eliminating it lowers it: that is the point of screening.

Yes, in the vast majority of cases, provided the full course is taken and eradication is checked afterwards. If it fails, another treatment is offered.

Not always. A breath or stool test is often enough to check. A repeat gastroscopy is sometimes needed, for example to confirm a stomach ulcer has healed.

Sources

  1. IARC (WHO) — Population-based Helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation, IARC Working Group Report No. 12, 2025
  2. IARC (WHO) — News release on the guidance, 2025
  3. Park JY et al. — Helicobacter pylori screen-and-treat programs for gastric cancer prevention, N Engl J Med, March 2026
Informational article written by Dr Youssef Bennani. It does not replace a consultation: if you have symptoms, see a doctor.
Directions